As interim Chief Financial Officer, Mr. Farabaugh leads all financial functions.
Mr. Farabaugh has more than 25 years of experience in financial leadership, including 15 years in the Life Sciences sector. Prior to TransEnterix, since August 2008, he served as Chief Financial Officer at Tryton Medical, a developer of coronary stents, where he also served as Chief Executive Officer since August 2019. Before Tryton Medical, Mr. Farabaugh was Chief Financial Officer at StrikeIron, Inc., a high-growth information technology company. He also served as Vice President of Finance for Icoria, Inc. (formerly Paradigm Genetics, Inc.) and held various positions at Nuada Pharmaceuticals and PricewaterhouseCoopers (PwC).
Mr. Farabaugh earned a BS in Commerce with a concentration in Accounting from the University of Virginia, and is a licensed CPA.